Back
Citius Pharmaceuticals Stock Price Chart
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE Trade
Sell
20
CTXR
Citius Pharmaceuticals
Last Price:
0.34
Seasonality Move:
14.95%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret Loophole- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight selling pressure.
Citius Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.37 | Sell |
| 20-day SMA: | 0.37 | Sell |
| 50-day SMA: | 0.47 | Sell |
| 200-day SMA: | 0.66 | Sell |
| 8-day EMA: | 0.36 | Sell |
| 20-day EMA: | 0.39 | Sell |
| 50-day EMA: | 0.46 | Sell |
| 200-day EMA: | 0.65 | Sell |
Citius Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 36.17 | Sell |
| Chaikin Money Flow: | -34056 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.36 - 0.42) | Sell |
| Bollinger Bands (100): | (0.42 - 0.78) | Sell |
Citius Pharmaceuticals Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Citius Pharmaceuticals Stock
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.35 while CTXR 8-day simple moving average is 0.37, which is a Sell signal.
- The stock price of CTXR is 0.35 while Citius Pharmaceuticals 20-day SMA is 0.37, which makes it a Sell.
- Citius Pharmaceuticals 50-day simple moving average is 0.47 while CTXR share price is 0.35, making it a Sell technically.
- CTXR stock price is 0.35 and Citius Pharmaceuticals 200-day simple moving average is 0.66, creating a Sell signal.
CTXR Technical Analysis vs Fundamental Analysis
Sell
20
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy or a Sell?
-
Citius Pharmaceuticals stock is rated a Sell
The current Citius Pharmaceuticals [CTXR] share price is $0.35. The Score for CTXR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Citius Pharmaceuticals Stock Info
Market Cap:
63.2M
Price in USD:
0.35
Share Volume:
351.91K
Citius Pharmaceuticals 52-Week Range
52-Week High:
1.07
52-Week Low:
0.33
Sell
20
Citius Pharmaceuticals (CTXR)
is a Sell
Citius Pharmaceuticals Share Price Forecast
-
What is the Citius Pharmaceuticals stock price today?
The Citius Pharmaceuticals stock price is 0.35 USD today. -
Will CTXR stock go up or go down?
Citius Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Citius Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Pharmaceuticals is overvalued.
Is Citius Pharmaceuticals Stock a Buy?
- Citius Pharmaceuticals share price is 0.35 while CTXR 8-day exponential moving average is 0.36, which is a Sell signal.
- The stock price of CTXR is 0.35 while Citius Pharmaceuticals 20-day EMA is 0.39, which makes it a Sell.
- Citius Pharmaceuticals 50-day exponential moving average is 0.46 while CTXR share price is 0.35, making it a Sell technically.
- CTXR stock price is 0.35 and Citius Pharmaceuticals 200-day simple moving average is 0.65, creating a Sell signal.
Fundamental Analysis of Citius Pharmaceuticals
Is Citius Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $0.33 per share.
Technical Analysis of Citius Pharmaceuticals
Should I short Citius Pharmaceuticals stock?
- CTXR Moving Average Covergence Divergence (MACD) indicator is -0.03, suggesting Citius Pharmaceuticals is a Sell
- Citius Pharmaceuticals Relative Strength Index (RSI) is 36.17, which suggest Citius Pharmaceuticals is oversold
- The Bollinger Bands (25) for Citius Pharmaceuticals is (0.36 - 0.42), which suggest Citius Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Citius Pharmaceuticals is (0.42 - 0.78), which suggest Citius Pharmaceuticals is a Sell
* Citius Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.